hVIVO poster presentation at ERS 2015 (European Respiratory Society International Congress) September 2015

October 7, 2015 11:05 am

“Discovering New Treatments for Asthma and COPD. The Use of the Human Viral Challenge Model with a Newly Manufactured and Characterised GMP Wild-Type Human Rhinovirus”.

Daniel J. Fullen, Bryan Murray, Daryl W. Borley, Julie Mori, Andrew Catchpole, Ganesh Balaratnam, Anthony Gilbert, Fiona Hughes & Rob Lambkin-Willams. hVIVO Group PLC, Queen Mary BioEnterprises Innovation Centre, 42 New Road, London , E1 2AX, England.


Human Rhinovirus (HRV) infection is an important precursor to asthma and chronic obstructive pulmonary disease (COPD) exacerbations. The Human Viral Challenge (HVC) model may provide a powerful tool in studying these and other chronic respiratory diseases. In this study, we have reported the production and human characterisation of a new Wild-Type HRV-16 challenge virus produced specifically for this purpose.

Fill out the form below to download the hVIVO poster presentation as made at ERS 2015.


Comments are closed here.

Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now